Trending Now
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Next-generation IOLs advance complex cataract care
OCT changes with low-level red light therapy for myopia in children
Alcon presenting at APACRS 2025
Breaking News
Popular Now
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
Collaborate With Us
Editor Choice
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ | Ophthalmology Times
(Image Credit: AdobeStock/Rawf8) LENZ Therapeutics and Lotus Pharmaceutical announced Lotus has submitted…
Phase 1 trial confirms safety and tolerability of Huons’ dry eye therapy | Ophthalmology Times
(Image Credit: AdobeStock) Huons Co, a pharmaceutical subsidiary of Huons Group, received…
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1 | Ophthalmology Times
(Image Credit: AdobeStock/doucefleur) Belite Bio has released topline results from the global…
Kiora Pharmaceuticals receives patent for additional and novel formulations of KIO-100 compounds | Ophthalmology Times
(Image Credit: AdobeStock/ronstik) The US Patent and Trademark Office has issued a…
Prevent Blindness delegates first week of December as 5th annual geographic atrophy week | Ophthalmology Times
(Image Credit: AdobeStock/Marina April) Prevent Blindness has declared the first week of…
Collarettes common but largely stable in moderate-to-severe dry eye patients | Ophthalmology Times
(Image Credit: AdobeStock/Alessandro Grandini) In utilizing the Dry Eye Assessment and Management…
Q&A: As DMEI turns 50, R. Michael Siatkowski, MD, MBA, looks to the future | Ophthalmology Times
R. Michael Siatkowski, MD, MBA, reflects on 50 years of innovation, research,…
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia | Ophthalmology Times
(Image Credit: AdobeStock/natali_mis) Editor’s Note: This content was generated with the assistance…
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined | Ophthalmology Times
(Image Credit: AdobeStock/Pixel-Shot) Editor’s Note: This content was generated with the assistance…
Worth Reading
Meeting expectations with evolving technology
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Next-generation IOLs advance complex cataract care
Subscribe Now
Enter your email address below and subscribe to our newsletter






















